CG Oncology (CGON) Assets Average (2024 - 2026)

CG Oncology (CGON) has 3 years of Assets Average data on file, last reported at $963.4 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average rose 29.93% year-over-year to $963.4 million; the trailing twelve-month figure through Mar 2026 stood at $963.4 million (up 29.93% YoY), and the FY2025 full-year result was $773.2 million, up 62.08% from the prior year.
• Assets Average for Q1 2026 stood at $963.4 million, up from $760.8 million in the prior quarter.
• Across five years, Assets Average topped out at $963.4 million in Q1 2026 and bottomed at $389.2 million in Q1 2024.
• The 3-year median for Assets Average is $714.8 million (2025), against an average of $674.3 million.
• Peak annual rise in Assets Average reached 90.51% in 2025, while the deepest fall reached 16.39% in 2025.
• A 3-year view of Assets Average shows it stood at $653.6 million in 2024, then gained by 16.39% to $760.8 million in 2025, then climbed by 26.64% to $963.4 million in 2026.
• The last three Assets Average figures came in at $963.4 million (Q1 2026), $760.8 million (Q4 2025), and $715.7 million (Q3 2025), per Business Quant data.

Peer Comparison